Our data show that PAR-2 and extra-pancreatic trypsinogen-3 (possible TAT-3) are both expressed in cell lines derived from human esophageal adenocarcinoma and Barrett’s esophagus, and exposing cells to trypsin accelerated cell proliferation in vitro. This evidence concerns the gene F2RL1 and esophageal adenocarcinoma.